Figures & data
Notes: (A) Overlapping protective prognostic gene markers (HR <1). (B) Overlapping risky prognostic gene markers (HR >1).
Abbreviations: HR, hazard ratio; TCGA-LAML, The Cancer Genome Atlas AML project.
Abbreviations: HR, hazard ratio; TCGA-LAML, The Cancer Genome Atlas AML project.
Notes: Kaplan–Meier curves of the 11 prognostic genes in the GSE12417 HG-U133A cohort. OS stratified by ACSF2 (A), CXCR6 (B), FAM124B (C), FRYL (D), GYPA (E), HBG1 (F), MAGOH (G), MDH2 (H), SLC2A5 (I), SUCLG1 (J), and TMC5 (K).
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
Notes: Kaplan–Meier curves of the 11 prognostic genes in the GSE12417 HG-U133 plus 2.0 cohort. OS stratified by ACSF2 (A), CXCR6 (B), FAM124B (C), FRYL (D), GYPA (E), HBG1 (F), MAGOH (G), MDH2 (H), SLC2A5 (I), SUCLG1 (J), and TMC5 (K).
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5.
Notes: Kaplan–Meier curves of the 11 prognostic genes in the TCGA LAML cohort. OS stratified by ACSF2 (A), CXCR6 (B), FAM124B (C), FRYL (D), GYPA (E), HBG1 (F), MAGOH (G), MDH2 (H), SLC2A5 (I), SUCLG1 (J), and TMC5 (K).
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5; TCGA-LAML, The Cancer Genome Atlas AML project.
Abbreviations: ACSF2, acyl-CoA synthetase family member 2; AML, acute myeloid leukemia; CXCR6, C-X-C motif chemokine receptor 6; FAM124B, family with sequence similarity 124 member B; FRYL, FRY-like transcription coactivator; GYPA, glycophorin A; HBG1, hemoglobin subunit gamma 1; MAGOH, mago homolog, exon junction complex core component; MDH2, malate dehydrogenase 2; OS, overall survival; SLC2A5, solute carrier family 2 member 5; SUCLG1, succinate-CoA ligase alpha subunit; TMC5, transmembrane channel like 5; TCGA-LAML, The Cancer Genome Atlas AML project.
Notes: (A) From top to bottom is the risk score, patients’ survival status distribution, and expression heat map of the 11 genes for low- and high-risk groups. (B) Kaplan–Meier curves for low- and high-risk groups. (C) ROC curve for predicting OS in AML patients by the risk score.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
Notes: (A) From top to bottom is the risk score, patients’ survival status distribution, and expression heat map of the 11 genes for low- and high-risk groups. (B) Kaplan–Meier curves for low- and high-risk groups. (C) ROC curve for predicting OS in AML patients by the risk score.
Abbreviations: AUC, area under the ROC curve; AML, acute myeloid leukemia; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
Abbreviations: AUC, area under the ROC curve; AML, acute myeloid leukemia; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic.
Notes: (A) From top to bottom is the risk score, patients’ survival status distribution, and expression heat map of the 11 genes for low- and high-risk groups. (B) Kaplan–Meier curves for low- and high-risk groups. (C) ROC curve for predicting OS in AML patients by the risk score.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic; TCGA-LAML, The Cancer Genome Atlas AML project.
Abbreviations: AML, acute myeloid leukemia; AUC, area under the ROC curve; CI, confidence interval; OS, overall survival; ROC, receiver operating characteristic; TCGA-LAML, The Cancer Genome Atlas AML project.
Notes: The difference in the expression level of the 11 genes between the low-risk group and high-risk group of the GSE12417 HG-U133A (A), GSE12417 HG-U133 plus 2.0 (B), and TCGA-LAML (C) cohorts. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
Abbreviation: TCGA-LAML, The Cancer Genome Atlas AML project.
Abbreviation: TCGA-LAML, The Cancer Genome Atlas AML project.